Silja Meier
Impact in
-
- Carcinogens and Genotoxicity Assessment
-
- Effects and risks of endocrine disrupting chemicals
- Environmental Toxicology and Ecotoxicology
Papers in
-
- Heart Failure Treatment and Management 5
- Cardiac electrophysiology and arrhythmias 2
- Cardiac pacing and defibrillation studies 2
-
- Carcinogens and Genotoxicity Assessment 3
- Co-authors
- Andrew Richard Collins (3 shared papers)Gunnar Brunborg (3 shared papers)Kristine B. Gützkow (2 shared papers)Amaya Azqueta (2 shared papers)Anne Graupner (1 shared paper)Torgrim Mikal Langleite (1 shared paper)Lise Román Moltzau (7 shared papers)Finn Olav Levy (7 shared papers)
- Journals
- British Journal of Pharmacology (1 paper)BMC Pharmacology and Toxicology (1 paper)Toxicology in Vitro (1 paper)European Journal of Pharmacology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- NorwayUnited KingdomGermany
In The Last Decade
Silja Meier
10 papers receiving 365 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 139
- Health, Toxicology and Mutagenesis 112
- Pollution 43
- Cardiology and Cardiovascular Medicine 76
- Chemical Health and Safety 2
Countries citing papers authored by Silja Meier
This map shows the geographic impact of Silja Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silja Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silja Meier more than expected).
Fields of papers citing papers by Silja Meier
This network shows the impact of papers produced by Silja Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silja Meier. The network helps show where Silja Meier may publish in the future.
Co-authors
The 25 scholars most cited alongside Silja Meier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 94 | |
| 2 | 2010 | 89 | |
| 3 | 2012 | 60 | |
| 4 | 2017 | 30 | |
| 5 | 2014 | 30 | |
| 6 | 2013 | 24 | |
| 7 | 2014 | 20 | |
| 8 | 2021 | 17 | |
| 9 | 2015 | 3 | |
| 10 | 2017 | 2 |
About Silja Meier
Silja Meier is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research, Health, Toxicology and Mutagenesis, Molecular Biology and Pharmacology, having authored 10 papers that have together received 369 indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (6 papers), Heart Failure Treatment and Management (5 papers), Carcinogens and Genotoxicity Assessment (3 papers), Effects and risks of endocrine disrupting chemicals (3 papers), DNA Repair Mechanisms (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Cardiac pacing and defibrillation studies (2 papers) and Radioactive contamination and transfer (1 paper). The work is most often cited by research in Cancer Research (139 citations), Health, Toxicology and Mutagenesis (112 citations), Pollution (43 citations), Cardiology and Cardiovascular Medicine (76 citations) and Chemical Health and Safety (2 citations). Silja Meier has collaborated with scholars based in Norway, United Kingdom and Germany. Frequent co-authors include Andrew Richard Collins, Gunnar Brunborg, Kristine B. Gützkow, Amaya Azqueta, Anne Graupner, Torgrim Mikal Langleite, Lise Román Moltzau, Finn Olav Levy, Jan Magnus Aronsen and Ivar Sjaastad. Their work appears in journals such as British Journal of Pharmacology, BMC Pharmacology and Toxicology, Toxicology in Vitro, European Journal of Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.